RFAs: GenScript Life Science Research Grant Program

This initiative is designed to empower researchers by offering grant funding specifically for purchasing GenScript reagents and services. Researchers from various life science fields are encouraged to apply and take advantage of this unique opportunity to advance their work.

Focus Areas

• Researchers in diverse life science fields, including but not limited to those listed below, are encouraged to apply and benefit from this unique opportunity to advance their work:
  • Gene and Cell Therapy Development
  • Antibody Drug Discovery
  • AI Drug Discovery
  • Vaccine Development
  • Diagnostics

Funding Information

• The maximum budget for each project is set at USD 100,000.00.
• Various grant funding levels will be considered, including 5,000-10,000, 10,000-50,000, and 50,000-100,000 USD.

Eligibility Criteria

• Research Focus: Proposals must align with the focus areas of the program in life science research areas including but not limited to gene and cell therapy development, antibody drug discovery, vaccine development, AI-driven drug discovery, or diagnostics.
• Geographic Location: Open to researchers globally. There are no restrictions based on geographic location, and international applicants are encouraged to apply.
• Entity Type: Eligible entities include academic/research institutions, universities, biotechnology companies, and other organizations engaged in life sciences research.
  • Any local, state, provincial, federal, or other government or government agency, and officials or employees thereof, are not eligible to participate.
  • Healthcare organizations, including hospitals, healthcare professionals, and employees thereof, are not eligible.
• Legal Status: Must be legally recognized and authorized to conduct research in their respective jurisdictions.
• Affiliation Restrictions: Employees of GenScript or its affiliates, as well as their immediate family members and household members, are ineligible to apply.
• Collaborations: Each eligible entity may submit only one (1) application representing the sole efforts of that entity. Collaborations among two (2) or more entities will not be considered unless GenScript provides explicit written consent.
• Compliance: Applicants must comply with all applicable federal, state, and local laws and regulations.
• Void Where Prohibited: The program is open to participants worldwide, except where prohibited by law. Participation constitutes the applicant’s full and unconditional agreement to the program’s rules and decisions, which are final and binding in all matters related to the grant.

For more information, visit GenScript.